Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MUV2.DE)
Munich, BY, DE
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. The company operates through six segments: Life and Health Reinsurance, Property-Casualty Reinsurance, Global Specialty Insurance, ERGO Life and Health Germany, ERGO Property-Casualty Germany, and ERGO International. The company offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, data analytics, underwriting and claims, medical research, capital management, and health market, as well as MIRA digital suite that includes MIRA PoS, MIRApply insured and physician, claims risk assessment, and CLARA plus. It also provides property and casualty reinsurance solutions, including agricultural reinsurance; business advisory, personal lines, portfolio management, insurance consulting, commercial motor consulting; infrastructure risk; property insurance, location risk, insurance linked securities, and NatCatSERVICE for natural catastrophe loss database; prospective structured and retroactive reinsurance; risk transfer; cyber; and data analytics, REALYTIX ZERO, and cert2go. In addition, the company offers solutions for industry clients, such as corporate risk, new tech, green tech, parametric, and aviation and space solutions, as well as risk services. Further, it provides specialty property casualty insurance, such as professional liability, marine, cyber, aviation, and space for commercial and private customers. Additionally, the company offers life, property-casualty, health, legal protection, and travel insurance products under the ERGO brand; and insurance solutions for agriculture, captive, epidemic, cyber, and renewable energy sectors. The company was founded in 1880 and is based in Munich, Germany.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.08% | +4.36% | -14.41% | -9.78% | -9.03% | -11.88% | -16.25% | +42.39% | +104.96% | +204.03% | +655.31% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 2 | 0 |
| Hold | 9 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 2 | 0 |
-
Revenue growth Insurance - Reinsurance: +19.7%+63.8% ★ Q1'26: +4.4% (vs Q1'25)
-
EPS growth Insurance - Reinsurance: +47.7%+10.2% Q1'26: +60.1% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Reinsurance: +7.0%-3.5% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Insurance - Reinsurance: +13.4%+13.0% Q1'26: +13.0% (vs Q1'25)
-
ROIC Insurance - Reinsurance: +4.0%+18.1% ★ Q1'26: +19.3% (vs Q1'25)
-
Share dilution Insurance - Reinsurance: +0.2%-2.4% ★ Q1'26: -2.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Reinsurance: 0.00×0.79× Q1'26: 0.84× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 12 EPS Ana. |
Dec 2027 3 Rev. Ana. 13 EPS Ana. |
Dec 2028 3 Rev. Ana. 11 EPS Ana. |
Dec 2029 2 Rev. Ana. 4 EPS Ana. |
Dec 2030 1 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
55.37B
est: 49.74B (+11.3%)
|
59.85B
est: 54.54B (+9.7%)
|
57.50B
est: 53.08B (+8.3%)
|
56.36B
est: 51.21B (+10.0%)
|
56.37B
est: 50.26B (+12.2%)
|
55.69B
est: 47.16B (+18.1%)
|
55.82B
est: 47.35B (+17.9%)
|
52.07B
est: 49.06B (+6.1%)
|
58.08B
est: 50.22B (+15.6%)
|
58.64B
est: 53.05B (+10.5%)
|
64.46B
est: 57.41B (+12.3%)
|
39.71B
est: 64.30B (-38.3%)
|
39.68B
est: 60.62B (-34.5%)
|
42.31B
est: 67.21B (-37.1%)
|
69.30B
est: 63.70B (+8.8%)
|
63.74B
56.96B – 66.20B
+0.1% YoY
|
66.35B
58.47B – 69.65B
+4.1% YoY
|
70.94B
62.95B – 74.08B
+6.9% YoY
|
73.62B
65.33B – 76.87B
+3.8% YoY
|
77.80B
69.04B – 81.24B
+5.7% YoY
|
| EBITDA |
1.45B
est: 3.34B (-56.6%)
|
4.55B
est: 164.49M (+2,667.3%)
|
4.33B
est: 3.91B (+11.0%)
|
3.70B
est: 3.00B (+23.4%)
|
4.44B
est: 2.69B (+64.8%)
|
4.18B
est: 3.33B (+25.5%)
|
961.00M
est: 3.76B (-74.4%)
|
3.74B
est: -222.68M (+1,781.4%)
|
4.15B
est: 2.81B (+47.6%)
|
1.82B
est: 3.43B (-46.9%)
|
4.47B
est: 3.59B (+24.5%)
|
13.17B
est: 3.72B (+254.3%)
|
7.72B
est: 11.55B (-33.2%)
|
9.41B
est: 12.80B (-26.5%)
|
9.36B
est: 12.14B (-22.9%)
|
12.15B
10.86B – 12.62B
+0.1% YoY
|
12.64B
11.14B – 13.27B
+4.1% YoY
|
13.52B
12.00B – 14.12B
+6.9% YoY
|
14.03B
12.45B – 14.65B
+3.8% YoY
|
14.83B
13.16B – 15.48B
+5.7% YoY
|
| EBIT |
1.45B
est: 3.55B (-59.2%)
|
4.55B
est: 574.63M (+692.2%)
|
4.33B
est: 4.25B (+2.0%)
|
3.70B
est: 3.70B (0.0%)
|
4.44B
est: 3.05B (+45.4%)
|
4.18B
est: 4.22B (-1.0%)
|
961.00M
est: 3.26B (-70.5%)
|
3.74B
est: 1.12B (+233.8%)
|
4.15B
est: 3.54B (+17.1%)
|
1.82B
est: 4.07B (-55.3%)
|
4.47B
est: 4.27B (+4.8%)
|
10.29B
est: 4.42B (+133.1%)
|
7.41B
est: 10.41B (-28.9%)
|
9.03B
est: 11.54B (-21.7%)
|
9.00B
est: 10.94B (-17.7%)
|
10.94B
9.78B – 11.37B
+0.1% YoY
|
11.39B
10.04B – 11.96B
+4.1% YoY
|
12.18B
10.81B – 12.72B
+6.9% YoY
|
12.64B
11.22B – 13.20B
+3.8% YoY
|
13.36B
11.85B – 13.95B
+5.7% YoY
|
| Net Income |
702.00M
est: 2.60B (-73.0%)
|
3.19B
est: 769.83M (+314.1%)
|
3.30B
est: 3.07B (+7.5%)
|
3.15B
est: 3.20B (-1.4%)
|
3.11B
est: 3.14B (-1.0%)
|
2.58B
est: 3.07B (-16.0%)
|
375.00M
est: 2.53B (-85.2%)
|
2.31B
est: 387.62M (+495.9%)
|
2.72B
est: 2.28B (+19.6%)
|
1.21B
est: 2.85B (-57.4%)
|
2.93B
est: 2.98B (-1.7%)
|
5.31B
est: 2.80B (+89.8%)
|
4.61B
est: 5.94B (-22.5%)
|
5.69B
est: 5.14B (+10.6%)
|
6.12B
est: 5.89B (+3.9%)
|
6.53B
6.37B – 6.68B
+10.8% YoY
|
6.81B
6.50B – 7.12B
+4.4% YoY
|
7.43B
7.10B – 7.76B
+9.1% YoY
|
8.22B
7.01B – 8.69B
+10.6% YoY
|
8.80B
7.51B – 9.30B
+7.0% YoY
|
| SGA |
2.68B
est: 7.17B (-62.7%)
|
2.79B
est: 7.86B (-64.5%)
|
2.74B
est: 7.65B (-64.2%)
|
2.74B
est: 2.61B (+4.7%)
|
2.99B
est: 2.75B (+8.9%)
|
2.95B
est: 2.94B (+0.2%)
|
2.96B
est: 2.94B (+0.7%)
|
3.03B
est: 3.15B (-4.0%)
|
3.13B
est: 3.02B (+3.8%)
|
2.84B
est: 3.53B (-19.5%)
|
3.00B
est: 3.70B (-18.8%)
|
7.81B
est: 3.83B (+104.0%)
|
8.62B
est: 8.15B (+5.7%)
|
8.97B
est: 9.03B (-0.7%)
|
—
est: 8.57B (-100.0%)
|
8.57B
7.66B – 8.90B
+0.1% YoY
|
8.92B
7.86B – 9.37B
+4.1% YoY
|
9.54B
8.47B – 9.96B
+6.9% YoY
|
9.90B
8.78B – 10.34B
+3.8% YoY
|
10.46B
9.28B – 10.92B
+5.7% YoY
|
| EPS |
3.94
est: 3.46 (+13.9%)
|
17.94
est: 17.72 (+1.2%)
|
18.45
est: 17.65 (+4.5%)
|
18.31
est: 18.83 (-2.7%)
|
18.73
est: 18.70 (+0.2%)
|
16.13
est: 16.74 (-3.7%)
|
2.44
est: 2.52 (-3.1%)
|
15.53
est: 15.57 (-0.3%)
|
18.96
est: 19.06 (-0.5%)
|
8.63
est: 8.88 (-2.9%)
|
20.94
est: 21.02 (-0.4%)
|
24.63
est: 23.66 (+4.1%)
|
33.88
est: 44.18 (-23.3%)
|
42.78
est: 42.41 (+0.9%)
|
47.15
est: 47.51 (-0.8%)
|
49.95
49.08 – 51.51
+5.1% YoY
|
52.48
50.09 – 54.91
+5.1% YoY
|
57.01
54.76 – 59.79
+8.6% YoY
|
63.34
54.07 – 66.98
+11.1% YoY
|
67.79
57.86 – 71.69
+7.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 5/5 | 4/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 5/5 | 4/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 5/5 | 4/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 5/5 | 4/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 5/5 | 4/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-05 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-15 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
No beneficial ownership filings recorded.
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ARISTOTLE CAPITAL MANAGEMENT, LLC | 185.8K -2.7K (-1.4%) | 122.68M +2.3M (+1.9%) | 0.14% -0.001 pp | 0.25% +0.013 pp | EUR251.31 +123.7% | 15 qtrs — |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Andrew James Buchanan | Chief Financial Officer & Member of Management Board | 3M | male |
| Christoph Jurecka | CEO & Chairman of Management Board | 3M | — |
| Michael Kerner | Member of Management Board | 3M | male |
| Clarisse Kopff | Member of Management Board | 3M | female |
| Mari Lizette Malherbe | Member of Management Board | 3M | female |
| Thomas Blunck | Member of Management Board | 3M | — |
| Achim Kassow | Chief Transformation Officer & Member of Management Board | 2M | — |
| Nicholas J. Gartside | Chief Investment Officer & Member of Management Board | 2M | male |
| Stefan Heinrich Golling | Member of Management Board & Labour Relations Director | 2M | male |
| Markus Riess | Head of Economics, Sustainability & Public Affairs and Member of Management Board | 1M | — |
| Soobum Lee | Head of the Operation | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MUV2.DE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
